Keyphrases
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Tumor Response
100%
Anal Cancer
100%
Metabolic Response
100%
Tumor Survival
100%
Positron Emission tomography-CT
100%
Anal Tumors
80%
Whole-body
40%
Progression-free Survival
40%
Fluorodeoxyglucose Uptake
40%
Cause-specific Survival
40%
Complete Metabolic Response
40%
Patient Outcomes
20%
Survival Rate
20%
Positron Emission Tomography
20%
Chemoradiotherapy
20%
Consecutive Patients
20%
Cox Proportional Hazards Model
20%
Response to Therapy
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Prospective Cohort Study
20%
Significant Predictors
20%
Patient Demographics
20%
Concurrent Chemotherapy
20%
Survival Outcomes
20%
Anal Carcinoma
20%
External Beam Radiotherapy
20%
Progression-free
20%
Predictors of Progression
20%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
F-18 Fluorodeoxyglucose
20%
Medicine and Dentistry
Neoplasm
100%
Positron Emission Tomography
100%
Fluorodeoxyglucose
100%
Anal Cancer
100%
Metabolism
100%
Anus Tumor
57%
Progression Free Survival
42%
Positron Emission Tomography-Computed Tomography
28%
Survival Rate
28%
Cause Specific Survival
28%
Proportional Hazards Model
14%
Prospective Cohort Study
14%
Fluorodeoxyglucose F 18
14%
External Beam Radiotherapy
14%
Patient Population
14%
Chemoradiotherapy
14%
Anus Carcinoma
14%